Compare · HUM vs MDXH
HUM vs MDXH
Side-by-side comparison of Humana Inc. (HUM) and MDxHealth SA (MDXH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HUM and MDXH operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $46.40B, about 2122.6x MDXH ($21.9M).
- Over the past year, HUM is up 78.0% and MDXH is down 81.6% - HUM leads by 159.6 points.
- HUM has been more active in the news (6 items in the past 4 weeks vs 4 for MDXH).
- HUM has more recent analyst coverage (25 ratings vs 5 for MDXH).
- Company
- Humana Inc.
- MDxHealth SA
- Price
- $398.00+3.06%
- $0.42+0.62%
- Market cap
- $46.40B
- $21.9M
- 1M return
- +7.77%
- -21.61%
- 1Y return
- +77.97%
- -81.58%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 6
- 4
- Recent ratings
- 25
- 5
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
MDxHealth SA
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Latest HUM
- Humana upgraded by Wells Fargo with a new price target
- SEC Form 4 filed by Director Hilzinger Kurt J
- The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants
- SEC Form 11-K filed by Humana Inc.
- SEC Form 11-K filed by Humana Inc.
- Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026
- Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State
- Humana Announces Agreement to Divest Minority Interest in Gentiva
- Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
Latest MDXH
- Amendment: SEC Form SCHEDULE 13G/A filed by MDxHealth SA
- SEC Form 6-K filed by MDxHealth SA
- Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial
- SEC Form 4 filed by Officer Sollee Joseph
- SEC Form 4 filed by Director Hardison Don M
- SEC Form 4 filed by Chief Executive Officer Mcgarrity Michael
- SEC Form 4 filed by VP, Finance and Accounting Oconnell Brendan
- SEC Form 4 filed by Director Hoffman Koen
- SEC Form 4 filed by Chief Commercial Officer Bellano John